Caspase Inhibition and Its Effects on T-Cell Lymphoma
Author Information
Author(s): Wang Sih-han, Martin Sean M., Harris Peter S., Knudson C. Michael
Primary Institution: University of Iowa
Hypothesis
Does inhibition of the apoptosome enhance mitophagy and promote oncogenesis in vivo?
Conclusion
Caspase inhibition does not significantly promote lymphoma formation in mice.
Supporting Evidence
- Casp9DN expression significantly delays in vitro apoptotic cell death in thymocytes.
- Casp9DN did not significantly accelerate T-cell lymphoma alone or in combination with other tumor-prone strains.
- Beclin 1 haploinsufficiency did not affect lymphoma formation in the studied models.
Takeaway
Scientists wanted to see if blocking a certain protein would help mice with cancer, but it didn't make a difference.
Methodology
Transgenic mice expressing a dominant negative form of Caspase-9 were used to study the effects on thymocyte viability and lymphoma formation.
Limitations
The study did not systematically determine tumor formation in organs other than the thymus.
Participant Demographics
Transgenic mice were used, specifically Lck-Casp9DN, Lck-Bax38/1, and Beclin 1+/− strains.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website